A research team led by Associate Professor Shinpei Yamaguchi and the late Professor Masako Tada of the Faculty of Science, together with Professor Yojiro Anzai and Lecturer Yohei Iizaka of the Faculty ...

Novartis reached a confidential settlement with Henrietta Lacks' family, resolving a second lawsuit over the nonconsensual use of HeLa cells.

Novartis becomes the second company to settle after being accused of reaping rewards from a racist medical system.

The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...

On Feb. 24, St. Pete Beach Commission discussed cell tower regulations as residents pushed for even more protections.

Henrietta Lacks’ cells were the first to reproduce in a laboratory, outside the human body, and have been used in ...

During a live event, Shaji Kumar, MD, discussed when talquetamab can be sequenced in multiple myeloma as an alternative to targeting BCMA in consecutive lines. Patients with relapsed/refractory ...

Ms. Lacks’s family accused Novartis of profiting from her cells, which were taken from her without her consent in 1951, when ...

Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES, February 27, 2026 /EINPresswire.com/ — ...

There are more than 170 rhinoviruses known to science. These causes of the common cold are found in noses all around you, and ...

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...

The last few decades have revealed that rhinovirus infections are behind a staggering number of asthma attacks, and for people with chronic obstructive pulmonary disease (COPD), they are a leading ...